Overview


According to FutureWise analysis the market for enteral feeding formulas in 2023 is US$ 5.71 billion, and is expected to reach US$ 11.98 billion by 2031 at a CAGR of 9.72%.

Enteral feeding is the process of consuming food through the gastrointestinal tract. The gastrointestinal tract is composed of the mouth, stomach, and esophagus. A tube delivers nutrition directly to the stomach and small intestine. This feeding method can be used to supplement or complete the caloric intake. In cases of critical injury, eating disorder, cancer, stroke attack, severe illness, or eating inability, the feeding method may be considered. Tube feeding is also known as enteral nutrition. It refers to any feeding method that relies on the gastrointestinal tract to provide calories, such as a normal oral diet and liquid supplements. The tube known as nasogastric or tube feeding is inserted through the nose into the stomach. A jejunostomy tube, on the other hand, is inserted directly through the skin. Patients with chronic conditions such as stroke, head trauma, cancer, and cancer can use the tube feeding formula. The nutrition formula is also used to help premature babies gain the necessary nutrition and medication.

Patients who are unable to eat or drink normally can be fed through an enteral feeding tube. These formulas are usually administered through a tube that is inserted into the stomach. All the nutrients your body requires to be healthy are provided by enteral feeding formulas. Enteral feeding uses a tube to deliver nutrients to the gastrointestinal tract. A patient who is unable to swallow or digest enough food but has a sufficient intestinal function. This can also refer to the introduction of nutritionally complete liquid formula directly into a patient's stomach or intestine with the aid of a narrow tube. Enteral nutrition is when an individual's oral intake is unsafe or inadequate to meet their nutritional needs. There are many types of enteral feeding tubes available depending on the route taken, such as an oral tube, nasal tube, and esophoria tube. These tubes can be made of silicon, PVC, or polyurethane. These tubes are used for short-term, enteral feeding. Their lengths range from 30 to 43 inches. The diameters of these tubes can be 8 to 14 inches for adults. Syringes and administration bottles (bottle, bag, etc.) are other equipment that can be used for enteral feed. Enteral pumps, giving sets, and syringes are all used for enteral feeding. You can classify enteral feeding formulas into two types: standard (polymeric), elemental, and semi-elemental, as well as disease-specific, blended, and modular. Enteral feeding is used in a variety of critical situations, such as liver failure, prolonged or severe anorexia, coma, or depressed sensorium and severe protein-energy under nutritional, failure to receive oral feedings due to neck trauma or head trauma, serious illnesses, or metabolic stress. Enteral feeding can also be used in cases of malabsorption, such as Crohn's disease or bowel formation in patients who are severely ill or starving.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Enteral Feeding Formulas Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Enteral Feeding Formulas Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Abbott
  • Danone SA
  • Fresenius Kabi
  • Nestlé
  • Victus, Inc.
  • Primus Pharmaceuticals, Inc.
  • Meiji Holdings. Co., Ltd.
  • Rickett Benckiser Group Plc

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Standard Formula
  • Disease-Specific Formula

By Flow Type

  • Intermittent Feeding Flow
  • Continuous Feeding Flow

By Stage

  • Adult
  • Pediatric

By Indication

  • Alzheimer’s
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By End-User

  • Hospitals
    • Cardiology
    • Neurology
    • Critical Care (ICU)
    • Oncology
    • Others
  • Home Care

By Sales Channel

  • Online Sales
  • Institutional Sales
  • Retail Sales

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Enteral Feeding Formulas Market By Product, By Flow Type, By Stage, By Indication, By End-User, By Sales Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Enteral Feeding Formulas Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Enteral Feeding Formulas Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Enteral Feeding Formulas Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Enteral Feeding Formulas Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Standard Formula
        2. Disease-Specific Formula

  • 8.   Enteral Feeding Formulas Market, By Flow Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Intermittent Feeding Flow
        2. Continuous Feeding Flow

  • 9.   Enteral Feeding Formulas Market, By Stage Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Adult
        2. Pediatric

  • 10.   Enteral Feeding Formulas Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Alzheimer’s
        2. Nutrition Deficiency
        3. Cancer Care
        4. Diabetes
        5. Chronic Kidney Diseases
        6. Orphan Diseases
        7. Dysphagia
        8. Pain Management
        9. Malabsorption/GI Disorder/Diarrhea
        10. Others

  • 11.   Enteral Feeding Formulas Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
         1.1. Cardiology
         1.2. Neurology
         1.3. Critical Care (ICU)
         1.4. Oncology
         1.5. Others
        2. Home Care

  • 12.   Enteral Feeding Formulas Market, By Sales Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Online Sales
        2. Institutional Sales
        3. Retail Sales

  • 13.   North America Enteral Feeding Formulas Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 14.   Latin America Enteral Feeding Formulas Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 15.   Europe Enteral Feeding Formulas Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 16.   Asia Pacific Enteral Feeding Formulas Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 17.   Middle East and Africa Enteral Feeding Formulas Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 18.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 19.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Abbott
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Danone SA
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Fresenius Kabi
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Nestlé
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Victus, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Primus Pharmaceuticals, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Meiji Holdings. Co., Ltd
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Rickett Benckiser Group Plc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 20.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 21.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients